Today: 30 June 2026

Marcin Frąckiewicz

Marcin Frąckiewicz is the founder and CEO of TS2 Space, a satellite communications company serving customers around the world. A graduate of the Warsaw School of Economics (SGH), he has more than two decades of experience in telecommunications, satellite services and technology ventures. He writes about satellite communications, space technology, artificial intelligence and the stock market, with a particular focus on technology companies, semiconductors, emerging industries and the trends shaping global innovation.

NVIDIA Stock Set to Soar? Latest AI Boom & Stock Forecast Revealed

AI Gold Rush Sends Nvidia Soaring: NVDA Stock Near Highs as $100B OpenAI Deal, China Ban & New Chips Define 2025

Nvidia’s stock has been on a rollercoaster this month, yet it remains near record levels. In early October, NVDA surged to an intraday all-time high around $195ts2.tech amid frenzied AI-driven buying. A mid-month pullback followed – the stock tumbled ~4% on profit-taking and macroeconomic jitters – but dip-buyers quickly stepped ints2.tech. By Oct. 21, NVDA was back around the low-$180s per share, only a few percent below its peakts2.tech. Year-to-date the stock has climbed about 30%, vastly outperforming the S&P 500, thanks to Nvidia’s status as the market’s premier “AI trade”ts2.tech. This resilience comes despite broader tech volatility. Rising bond yields and other macro headwinds spooked growth stocks in mid-October, but investors continue to gravitate to Nvidia on any dipsts2.tech. Heavy trading volumes reflect intense interest in the namets2.tech. “High valuations and interest-rate jitters” sparked some profit-taking, one analyst noted, yet most see the pullback as a temporary breather for an otherwise strong uptrendts2.tech. At around 50× forward earningsts2.tech, NVDA isn’t cheap, but believers argue its growth prospects justify a premium.
21 October 2025
··
Battle of the EV Charging Standards: Tesla’s NACS vs. CCS2 vs. CHAdeMO – Who Will Rule the Roads in 2025?

Tesla Stock’s High-Stakes Surge: Record Sales, Price Cuts, and Musk’s $1 Trillion Gambit – What’s Next for TSLA?

Tesla’s stock has been on a tear heading into late October. Shares of the EV giant hovered in the mid-$440s on October 21, within a whisker of their 52-week high set earlier in the monthts2.tech. The stock’s momentum reflects a mix of optimism and jitters: Tesla has dramatically outpaced the broader market this year, yet recent sessions have seen volatile swings as traders brace for the company’s quarterly earnings report. A 5% surge one day followed by a sharp pullback the next has been typical of Tesla’s rollercoaster trading pattern, underscoring the market’s nervous excitement ahead of earnings. Analysts say this volatility shows investors are “on edge” – bullish about Tesla’s growth, but wary of any bad news that could snap the rally. What’s driving the enthusiasm? In large part, Tesla’s record-breaking Q3 sales have given bulls justification to bid the stock higher. Earlier this month, Tesla revealed it delivered 497,099 vehicles worldwide in Q3, shattering its previous records and coming in well above consensus forecaststs2.tech. Deliveries grew roughly 7.4% year-over-year – a remarkable feat for an automaker of Tesla’s scale – and signaled resilient demand. Much of this blowout was thanks to a last-minute sales rush in late September:
21 October 2025
··
Gold Hits $4,000 as AI Frenzy Pushes Stocks Near Record – Boom or Bust Ahead?

Gold’s Record Surge and Shocking Slump: Inside 2025’s Wild Gold Ride

Gold’s ascent in 2025 has been nothing short of staggering. After breaking above the $4,000/oz milestone for the first time ever in early October, the yellow metal went nearly parabolic. By October 20, spot gold spiked to about $4,381 per ounce, a fresh all-time hights2.tech. It then hovered near $4,300 the next day – even a 1–2% dip still left prices in the stratosphere relative to a year ago. To put the rally in perspective, gold was trading around $2,650 at the start of 2025; by late October it had vaulted ~60% higherreuters.com. “Gold’s strength reflects an extremely positive macroeconomic and geopolitical background for safe-haven assets,” noted Matthew Piggott of Metals Focus, reflecting the widespread investor anxiety propelling the metalts2.tech. Virtually no other major asset has matched gold’s performance this year. Stocks, bonds, and even other commodities lagged far behind gold’s gainsts2.tech. Silver did surge in sympathy – silver hit a 14-year high around $54.5/oz in mid-Octoberts2.tech – but even that paled next to gold’s record-breaking climb. In fact, by October 17 gold was briefly on track for its biggest weekly gain since 2008reuters.com. “Gold broke above $4,300/oz for the first time on Thursday,” Reuters reported that week, noting the
21 October 2025
··
Galaxy Digital (GLXY) Stock Soars on Massive Bitcoin Deal and Blowout Earnings

Galaxy Digital (GLXY) Stock Soars on Massive Bitcoin Deal and Blowout Earnings

Galaxy Digital’s stock has been on a wild ride over the past several days. After sliding late last week – GLXY fell about 5.7% on Friday, Oct. 17 on broader market weakness – the stock roared back as crypto markets recovered. On Monday, Galaxy’s shares spiked intraday nearly 10% after a bullish analyst call. Rosenblatt Securities issued a buy rating and raised its price target to $44, declaring confidence in Galaxy’s prospectsmarketbeat.com. GLXY hit ~$41.7 during Monday’s trading and closed up almost 5% on the daymarketbeat.comstockanalysis.com. That momentum only intensified early Tuesday once Galaxy released its earnings. In pre-market trade Oct. 21, GLXY surged another ~10% to around $44marketscreener.com. By mid-day Tuesday the stock was hovering near that level, marking a ~15% jump in two days and trading near its 52-week highs. Year-to-date, Galaxy Digital has more than doubled in valuemarketscreener.com, vastly outperforming the broader market, thanks to rising crypto optimism.
21 October 2025
···
Philip Morris (PM) Stock Surges as Forecast Raised Again – Smoke-Free Push Ignites Rally

Philip Morris (PM) Stock Surges as Forecast Raised Again – Smoke-Free Push Ignites Rally

Philip Morris International’s stock got a fresh jolt after the company announced better-than-expected third-quarter results and lifted its full-year outlook yet again. Adjusted Q3 earnings came in at $2.24 per share, handily beating analyst estimates of about $2.09reuters.com. The earnings beat – coupled with management’s third upward profit forecast revision of 2025 – signaled strong business momentum. In response, PM shares climbed ~4–5% in pre-market trading on October 21ts2.tech, and by midday the stock was hovering around the upper-$150s per share. This continues a strong 2025 run for PMI stock, which has returned roughly 30% year-to-datesimplywall.st. Investors cheered the news that Philip Morris now expects full-year adjusted earnings of $7.46 to $7.56 per share, slightly above its prior guidance and ahead of analyst consensusreuters.com. The repeated forecast hikes underscore management’s confidence as 2025 winds down. Financial experts note that PMI’s market performance has been impressive amid a volatile year. “The stock has surged this year, underscoring a shift toward income and value in a choppy market,” observed a TS2 analysis, pointing to Philip Morris’s appeal for long-term investorsts2.tech. Even after recent gains, one valuation model suggests PM may be undervalued – Simply Wall St estimates a fair value near $202
21 October 2025
·
Volkswagen Faces Shutdown as Chip War Escalates – Global Auto Industry on Edge (Nexperia)

Volkswagen Faces Shutdown as Chip War Escalates – Global Auto Industry on Edge (Nexperia)

A new chip crisis is looming over Volkswagen just as the industry hoped supply shortages were easing. Nexperia – a major supplier of the tiny electronic components that go into every modern vehicle – has told automakers it “could no longer guarantee” chip deliveries as of mid-Octoberreuters.com. The warning came after an unprecedented intervention by the Dutch government: on September 30, officials invoked emergency laws to take control of Nexperia, ousting its China-appointed CEO amid concerns sensitive technology could leak to Chinareuters.comreuters.com. Beijing swiftly retaliated. China’s Commerce Ministry issued an export ban effective October 4 that prohibits Nexperia’s China factories from shipping out certain chip productsreuters.com. In effect, a huge slice of Nexperia’s production – much of which is assembled or tested in China – is now cut off from the global market. Nexperia’s headquarters called the situation a contractual force majeure and scrambled to allocate its limited inventory to customerstrendforce.com. But for automakers, many of which rely on Nexperia’s chips, the sudden freeze set off alarms.
21 October 2025
·
Minerva Neurosciences Stock Skyrockets on $200M Lifeline for Schizophrenia Drug

Minerva Neurosciences Stock Skyrockets on $200M Lifeline for Schizophrenia Drug

Minerva Neurosciences’ stock chart went vertical on Tuesday after the biotech announced an expansive financing deal that effectively triples the company’s market capitalization overnightmarketbeat.com. In pre-market trading on Oct. 21, NERV stock jumped as much as 160% on the newsgurufocus.com. The shares opened around $6–7 and oscillated near those levels through the day, ultimately marking a 52-week high of $6.97marketbeat.com. By comparison, NERV had traded as low as $1.15 within the past yearmarketbeat.com, reflecting both the dramatic rebound and the extreme volatility inherent in this micro-cap biotech. Such a parabolic one-day gain is rare and signals intense investor interest. Indeed, volume on Oct. 21 exceeded 39 million shares, hundreds of times the normal daily volume around a few hundred thousandtipranks.commarketbeat.com. The frenzy suggests that news of the funding deal – which shores up Minerva’s cash position and chances of advancing its drug – triggered a rush of speculative buying, short covering, or both. Just a day earlier, the stock had quietly risen about 5–7% in anticipationtipranks.com. But once the full details hit the wire Tuesday morning, NERV skyrocketed, ultimately closing the session up roughly 150% from the prior day.
21 October 2025
··
iBio Stock Surges on Bullish Analyst Calls and Obesity Drug Breakthroughs

iBio Stock Surges on Bullish Analyst Calls and Obesity Drug Breakthroughs

As of midday October 21, 2025, iBio’s stock trades around $0.89 per sharemarketbeat.com. The price has been volatile in recent days. Last week, shares jumped over 20% in pre-market trading on October 17 after Leerink Partners issued a bullish initiation, although the stock later settled near $0.85 by that day’s closemarketbeat.com. Even with these upticks, iBio’s stock remains well below its levels earlier this year – it began 2025 at ~$2.45 and has declined about 63% year-to-datemarketbeat.com. This underperformance comes amid broader small-cap biotech volatility; by comparison, the biotech sector ETF is up roughly 20% in 2025finance.yahoo.com. iBio’s modest market capitalization and thin trading volume reflect its micro-cap statusmarketbeat.comreuters.com, which can magnify price swings on news. Wall Street analysts have taken notice of iBio’s potential. This week Oppenheimer initiated coverage on iBio with an “Outperform” rating and a bold $5.00 price targetgurufocus.com. That target implies massive upside from current levels – well over 400% above the sub-$1 share price. Just days earlier, Leerink Partners’ analyst Roanna Ruiz also launched coverage at “Outperform” with a $2.00 targetgurufocus.com. These back-to-back bullish calls suggest growing confidence in iBio’s prospects. “Based on the one-year price targets offered by 4 analysts, the average target price
21 October 2025
·
UnitedHealth Stock Rallies to $364 – Will UNH’s 2025 Comeback Last or Fade?

UnitedHealth Stock Rallies to $364 – Will UNH’s 2025 Comeback Last or Fade?

UnitedHealth stock has seen volatile swings in 2025, but recent weeks brought a measure of relief. As of Oct. 21, shares trade around $364, up from the lows hit earlier in the year. On Monday, UNH jumped +2.21% to close at $364.48investing.com, recovering from a mid-month dip. Over the past week the stock oscillated in the mid-$350s to $360s, essentially flat to slightly higher overallinvesting.com. Despite this stabilization, UnitedHealth remains deep in the red for 2025. The stock is still down roughly 30–35% year-to-datets2.tech, dramatically underperforming the broader market. The collapse earlier in the year leaves UNH about 40% below its 2025 highs – in April the stock traded above $630, versus the mid-$360s nowts2.tech. This wide gap is reflected in the 52-week range of $234.60 to $630.73ts2.tech, highlighting the severity of the sell-off.
21 October 2025
·
Equifax Stock Jumps as Earnings Beat Forecasts – Guidance Hiked, Analysts See Upside

Equifax Stock Jumps as Earnings Beat Forecasts – Guidance Hiked, Analysts See Upside

Equifax’s stock has been range-bound in recent weeks, hovering in the low-$230s per share. It closed at $231.12 on Oct. 20investing.com, and despite a solid year-to-date performance in 2025, shares remain about 15% lower than a year agoinvesting.com. Elevated interest rates and recession worries weighed on credit industry stocks earlier this year. However, sentiment has improved recently as the Federal Reserve’s policy outlook turned more dovish this fall and tech-focused stocks rebounded. Equifax stock is up roughly 2% for 2025 so far, outperforming some peers, and has climbed about 50% over the past five years. In the past week, EFX shares traded relatively flat ahead of earnings, then ticked higher on Oct. 21 after the company’s upbeat report. The early-morning earnings release and guidance hike spurred modest buying in pre-market trading. By midday Tuesday, Equifax stock was trading in the green, as investors digested the news of better-than-expected results and an improved outlook. Volume was above average, indicating heightened interest from both institutional and retail investors post-earnings.
21 October 2025
··
Elevance Health Stock Soars on Massive Q3 Earnings Beat – What It Means for Investors

Elevance Health Stock Soars on Massive Q3 Earnings Beat – What It Means for Investors

Elevance Health posted strong third-quarter 2025 results, significantly outperforming market expectations on both profit and revenue. Adjusted earnings came in at $6.03 per share, well above the ~$4.95 analysts predictedinvesting.com. Likewise, revenue for the quarter reached $50.1 billion, surpassing the $49.3 billion consensus and growing 12% year-over-yearinvesting.com. This robust growth was fueled by higher premium yields and an expanding customer base – particularly gains in Medicare Advantage enrollments – along with contributions from recent acquisitions in Elevance’s Carelon health services unittradingview.com. These factors combined to help Elevance smash its Q3 forecasts, showcasing strong demand and pricing power in its health benefits business. Investors reacted enthusiastically to the earnings news. Elevance’s stock price surged in pre-market trading, rising over 7% before the market opened Tuesdayreuters.com. The rally signaled relief and optimism that the company’s performance is outpacing expectations despite cost pressures. Upon the market open, ELV shares hovered in the mid-$350s – roughly flat versus Monday’s close, as some early gains moderated. Even so, the stock was still up about 15% from a month earliersimplywall.st, reflecting building momentum ahead of the results. The upbeat Elevance report also gave a jolt to other health insurers: UnitedHealth Group and Centene saw their stocks
21 October 2025
····
Danaher (DHR) Stock Surges on Earnings Beat as Analysts Eye Upside (Oct 21, 2025)

Danaher (DHR) Stock Surges on Earnings Beat as Analysts Eye Upside (Oct 21, 2025)

Danaher’s shares have been on a steady climb in recent weeks, hovering around the $208 mark as of October 21, 2025. This puts the stock roughly back to early-year levels and marks a solid rebound from its summer lows. In fact, DHR has gained about 8% over the past month and 10% over the past quarter, outpacing many peers in the life sciences sectorts2.tech. This rally suggests renewed investor interest in Danaher and its industry, possibly driven by anticipation of the Q3 earnings and optimism around new product developments. Despite the recent uptick, it’s important to note that Danaher is still in the red on a year-over-year basis. The stock’s 12-month return is approximately –20%, reflecting broader challenges that hit life science tool companies following the pandemic boominvesting.com. A year ago, Danaher traded closer to $260, so today’s price near $208 indicates it has not yet regained those highs. Analysts point out that the long-term backdrop still needs improvementts2.tech, but the current momentum has been encouraging. The question is whether DHR can sustain this uptrend or if it will consolidate as investors digest its outlook.
21 October 2025
··
GM Stock Skyrockets 7% as Earnings Beat, EV Strategy U-Turn Fuel Rally

GM Stock Skyrockets 7% as Earnings Beat, EV Strategy U-Turn Fuel Rally

A water tower with the GM logo stands over a General Motors facility. GM’s stock jumped after the automaker’s Q3 2025 earnings topped expectations and guidance was raised, signaling resilience despite industry headwindsng.investing.comng.investing.com. General Motors shares soared in Tuesday’s trading after the Detroit automaker delivered a surprise earnings beat for the third quarter and upgraded its outlook for the year. By midday, GM’s stock price was up about 6.6%, hovering around $61–$62 per share – among its biggest single-day gains of 2025. This jump brings the stock within a whisker of its 52-week highmarketbeat.com, and extends a steady upswing over recent weeks. In comparison, GM had closed at $58.00 the day before after a mild 0.7% dip ahead of the earnings newsbenzinga.com. The earnings-fueled rally reflects investor relief that GM’s core business remains robust even as the company navigates an uncertain EV transition.
21 October 2025
··
3M Stock Set to Soar! PFAS Settlement and Dividends Spark Rally (Oct 2025)

3M Stock Soars on Earnings Beat & Turnaround Progress – What Investors Need to Know

3M’s stock has been grinding higher in 2025 after a rough prior decade. Shares are hovering in the mid-$150s – near their highest levels of the past year, though still below pre-2020 peaks. As of the Oct. 20 close, MMM was at $154.78, having climbed about +17.5% in the past 12 monthsca.investing.com. By comparison, the S&P 500 is up roughly mid-teens percentage over a similar period. Year-to-date, 3M’s gains are in the high single digits to low teens range, depending on the baseline – a notable improvement considering the stock languished near multi-year lows around $120–$130 not long ago. In October specifically, 3M’s stock saw a bit of turbulence. It traded in the $145–$155 range through early Octoberts2.tech, then dipped about 6% in one week amid a general market pullbackts2.tech. However, momentum shifted leading into mid-month: the Dow Jones Industrial Average rallied strongly on hopes of easing interest rates and positive earnings from tech giants. 3M’s shares rebounded back to the high-$140s and then into the $150s ahead of its own earnings. On Monday Oct. 20, the stock jumped alongside a broad market surge. Premarket on Oct. 21, following 3M’s earnings release, MMM shares were indicated up about +1%bloomberg.com as
21 October 2025
··
IDFC First Bank Stock Soars 7% After Profit Surge – What’s Next for its Share Price?

IDFC First Bank Stock Soars 7% After Profit Surge – What’s Next for its Share Price?

IDFC First Bank’s stock has been on a tear, soaring about 7% in a single session after the lender delivered stellar Q2 FY2025-26 results. On October 20, the share price hit approximately ₹77 – its highest level in nearly 11 months – as investors cheered a 75% jump in quarterly profitmoneycontrol.com. This upbeat earnings surprise sparked a rally that far outpaced the broader market and peer banks. In fact, IDFC First was the top gainer among major private lenders following the Q2 results: its ~5–7% surge on the day eclipsed gains in Yes Bank and HDFC Bank, while ICICI Bank’s shares fell ~2.5% despite that bank posting profit growthlivemint.com. The exuberant reaction has brought IDFC First’s stock within touching distance of its 52-week high of around ₹78.5business-standard.combusiness-standard.com, prompting investors to ask – what’s driving this bank’s outperformance, and can it continue? The trigger for the latest rally was IDFC First Bank’s strong July–September earnings, which handily beat street expectations. Net profit surged to ₹352.3 crore, up 75.5% year-on-year, fueled by robust core operating performancemoneycontrol.com. The bank’s net interest income – essentially income from lending after interest expenses – rose to ₹5,113 crore, marking ~6.8% YoY growthmoneycontrol.com. Total interest earned grew
21 October 2025
·
ICICI Bank Stock at ₹1,380 Today – Analysts Eye ₹1,800 Target After Q2 Earnings Shock

ICICI Bank Stock at ₹1,380 Today – Analysts Eye ₹1,800 Target After Q2 Earnings Shock

As of October 21, 2025, ICICI Bank’s stock traded around ₹1,380 per share, slightly in the red for the daylivemint.com. The price is down about 0.5% from the previous close of ~₹1,390, continuing to linger after a sharp fall on Monday. On October 20, the stock plunged over 3% intraday, hitting lows near ₹1,389 before closing around ₹1,390.90hindustantimes.com. This drop erased gains from the prior week – ICICI had been trading above ₹1,430 last Friday before earnings. Despite the recent volatility, the stock remains up roughly 8–9% in 2025 so farlivemint.com, outperforming broader indices. It is currently about 7% below its 52-week high of ₹1,494livemint.com. The trading volumes have been elevated during the earnings week, indicating active investor participation. On Monday, volumes spiked as traders reacted to the results and outlook. Analysts note that ICICI’s valuation reflects high expectations – the stock trades at ~18 times trailing earnings, almost double the sector P/E of ~9livemint.com. Its price-to-book ratio is above peers’, underscoring the market’s confidence in ICICI’s growth and asset quality. However, that premium also means any disappointment can trigger profit-taking, as seen this week.
21 October 2025
·
South Indian Bank Stock Soars to Record High on Q2 Earnings – Will ₹50 Be Next?

South Indian Bank Stock Soars to Record High on Q2 Earnings – Will ₹50 Be Next?

South Indian Bank’s stock price has been on fire, soaring to an all-time high this week on the back of strong earnings and bullish investor sentiment. On October 21, the scrip touched approximately ₹38.4 during the Muhurat trading session, building on the previous day’s big gainslivemint.com. At ₹38+, the share is trading at levels never seen before in the bank’s historybusinesstoday.in. For context, the stock was hovering around ₹32 just before the results – meaning it’s leapt about 15–18% in two trading sessions alone. This latest jump extends what has already been an impressive run in 2025. Year-to-date, South Indian Bank has climbed over 50% in valuelivemint.com, vastly outperforming broader market indices. In just the last five trading days, it has added about 14%livemint.com, indicating accelerating momentum. The rally has lifted SIB’s market capitalization past ₹10,000 crore5paisa.com, firmly placing it among notable mid-tier banks in India. By comparison, many larger private banks are up only modestly this year, so SIB’s steep ascent has caught the market’s attention.
21 October 2025
··
RRP Semiconductor Stock Skyrockets 57,000%; Sachin Tendulkar Link Debunked

Mystery Chip Stock Soars ~57,000% to ₹9,500 – RRP Semiconductor’s Frenzy Triggers Bubble Fears

RRP Semiconductor Ltd – a microcap firm virtually unheard of a year ago – has stunned the market with an eye-popping stock price surge. The company’s share price climbed from just ₹15 in April 2024 to about ₹9,300+ by October 2025, an increase of several thousand-foldenglish.mathrubhumi.com. As of October 21, 2025, RRP opened at ₹9,478 per share and immediately hit its 2% upper circuit for the dayinvesting.com. This caps a streak of consecutive upper-limit gains in recent sessions, with the stock rising roughly 2% each trading day over the past week. Year-to-date in 2025 alone, RRP’s stock has multiplied over 48-foldts2.tech, and since its listing 18 months ago it’s up about 57,000%moneycontrol.com – a virtually unheard-of return for any public company. Such meteoric gains have turned RRP into a so-called “multibagger” phenomenon, attracting attention – and concern – across the market. For context, an investment of ₹1 lakh in RRP at the start of 2025 would now be worth well over ₹45 lakhts2.tech. A ₹10 lakh investment at listing in 2024 could have theoretically grown into the hundreds of crorests2.tech. This spectacular wealth creation on paper has understandably piqued curiosity among retail investors, with many scrambling to understand what’s behind
21 October 2025
··
Duralex Crisis Deepens: Iconic French Glassmaker Seeks €5M Lifeline from Public Investors

Duralex Crisis Deepens: Iconic French Glassmaker Seeks €5M Lifeline from Public Investors

Founded in 1945, Duralex is a household name in France, known worldwide for its nearly indestructible tempered glass cups and plates. The company is considered part of France’s industrial patrimoine – a storied legacy spanning roughly 70 years of glassmakingbfmtv.com. But that proud history has been marred by repeated crises. Over the past three decades, Duralex has endured multiple bankruptcies and rescues, as successive owners failed to modernize its factory in La Chapelle-Saint-Mesmin. By 2020, amid mounting debt, Duralex entered court-administered reorganization, and a new investor took over in 2021decideurs-cf.com. That revival effort quickly soured. In late 2022, Europe’s energy crisis – exacerbated by Russia’s invasion of Ukraine – caused natural gas prices to explode, forcing Duralex to pause its furnace for months to cut costsangers.maville.com. The company survived by drawing down inventory, but the production halt hit revenues hard. At the same time, high inflation eroded consumer spending on household goodsangers.maville.com, slowing Duralex’s post-COVID recovery. By summer 2024, the company was once again on the verge of liquidationbfmtv.com.
21 October 2025
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 21.10.2025

{“@context”:”https://schema.org”,”@type”:”LiveBlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-21-10-2025/#live”,”headline”:”Stock Market Today 21.10.2025″,”description”:”Live rolling coverage of technology news: AI, chips, gadgets, software, startups, cybersecurity, telecom, and policy.”,”datePublished”:”2025-10-21T06:00:02-04:00″,”dateModified”:”2025-10-23T06:44:02-04:00″,”coverageStartTime”:”2025-10-21T06:00:02-04:00″,”coverageEndTime”:”2025-10-23T06:44:02-04:00″,”author”:{“@type”:”Organization”,”name”:”TechStock²”},”publisher”:{“@type”:”Organization”,”name”:”TechStock²”,”logo”:{“@type”:”ImageObject”,”url”:”https://ts2.tech/wp-content/uploads/2024/02/cropped-ts2-logo-google.png”}},”inLanguage”:”en-US”,”liveBlogUpdate”:[{“@type”:”BlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-21-10-2025/#live/u/e4e7152bb08cf7a6″,”headline”:”Weatherford International Q3 Earnings Miss; Profit Drops, Revenue Declines”,”articleBody”:”Weatherford International (WFT) reported Q3 earnings of $81 million, or $1.12 per share, down from $157 million or $2.06 per share a year earlier. Analysts had expected about $1.19 per share in EPS, meaning the report missed estimates. Revenue declined 12.6% to $1.232 billion from $1.409 billion last year. The results underscore ongoing pressure on Weatherfordu0027s activity levels and markets. Overall, EPS and revenue failed to meet expectations.”,”datePublished”:”2025-10-21T19:06:13-04:00″,”dateModified”:”2025-10-21T19:06:13-04:00″,”mainEntityOfPage”:”https://ts2.tech/en/stock-market-today-21-10-2025/#u-e4e7152bb08cf7a6″,”url”:”https://ts2.tech/en/stock-market-today-21-10-2025/#u-e4e7152bb08cf7a6″},{“@type”:”BlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-21-10-2025/#live/u/186d92a4a72c8603″,”headline”:”Wall Street ends mixed as earnings lift the
21 October 2025
·
1 … 259 260 261 262 263 … 397

Stock Market Today

  • Rocket Lab Jumps After Striking $8 Billion Iridium Buyout
    June 29, 2026, 10:59 PM EDT. Rocket Lab Corp. (NASDAQ:RKLB) shot up 15.93% and ended at $98.01 after announcing an $8 billion takeover of Iridium Communications Inc. The combined cash and stock deal puts Iridium's value at $54 a share, 24% over its previous close. Rocket Lab says it's moving to create an integrated space business by adding Iridium's satellite network to its launch services. CEO Peter Beck said the plan is to use Iridium's infrastructure alongside Rocket Lab's production and launch capability to go after more markets and build out space applications. Deal completion is targeted for mid-2027, pending shareholder and regulatory sign-off. Rocket Lab's push into satellite communications comes as the sector keeps consolidating.
Go toTop